ESMO Colorectal Oncology Conference Review 2006 - reviewed by Dr David Porter

In this issue:

Xelox vs FOLFOX with bevacizumab
Cetuximab dose-escalation
Cetuximab in elderly patients - first line
FDG - PET to predict response
Irinotecan first line meta-analysis
Oxaliplatin plus capecitabine - first line
Xeliri vs Saltz - first line
FOLFOX4 and PTK787/ZK
Capecitabine vs bolus 5-FU/LV
Oxaliplatin, capecitabine plus preoperative radiotherapy

Download PDF Subscribe